XENCOR ANNOUNCES PROFFERED PAPER ORAL PRESENTATION AT ESMO 2026 FOR PHASE 1 CLINICAL STUDY OF XMAB819 IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

Reuters · 1d ago

Please log in to view news